Provided by Tiger Trade Technology Pte. Ltd.

SHINEWAY PHARM

8.340
-0.035-0.42%
Volume:3.94M
Turnover:33.08M
Market Cap:6.90B
PE:6.62
High:8.495
Open:8.445
Low:8.325
Close:8.375
52wk High:8.838
52wk Low:6.408
Shares:827.00M
HK Float Shares:827.00M
Volume Ratio:2.02
T/O Rate:0.48%
Dividend:1.42
Dividend Rate:17.03%
EPS(LYR):1.260
ROE:10.05%
ROA:3.90%
PB:0.72
PE(LYR):6.62
PS:2.22

Loading ...

China Shineway FY26 H1 Profit Drops 23.7% to RMB 469.16 Million; Revenue Falls 28.5% to RMB 1.18 Billion

Reuters
·
Aug 27

China Shineway Pharma Declares RMB 0.8 Fy2026 Second Interim Dividend

Reuters
·
Aug 27

China Shineway Pharma Schedules Board Meeting on Interim Results, Dividend Decision

Reuters
·
Aug 17

Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?

Simply Wall St.
·
Jul 17

Shineway Pharma AGM Clears All Motions; Confirms Board Line-up and 20% Share Issuance Mandate

Bulletin Express
·
May 28

SHINEWAY PHARM Reports 18% Revenue Decline in Q1 2026

Stock News
·
May 07

China Shineway Pharmaceutical - Q1 Turnover RMB624 Mln

THOMSON REUTERS
·
May 07

China Shineway Q1 turnover falls 18% to RMB 624 million

Reuters
·
May 07

Tianjin Binhai Teda Logistics unit Yuan Da Logistics pays RMB 7.16 million in back taxes

Reuters
·
Apr 30

China Shineway Pharmaceutical Releases 2025 Annual and ESG Reports; AGM Materials Now Online

Bulletin Express
·
Apr 23

China Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report

Bulletin Express
·
Apr 23

Shineway Pharmaceutical’s 2025 ESG Report: Higher Carbon Footprint Offset by Waste-Reduction Gains and Strong Social Commitments

Bulletin Express
·
Apr 23

Shineway Pharmaceutical to Seek Shareholders’ Approval on Financials, Board Re-elections and 20% Issuance Mandate at 28 May 2026 AGM

Bulletin Express
·
Apr 23

China Shineway Pharmaceutical publishes 2025 annual report

Reuters
·
Apr 23

SHINEWAY PHARM 2025年业绩:收入承压净利逆势增长,聚焦创新中药与成本管控

Bulletin Express
·
Apr 23

Shineway Pharma Shares Climb Over 4% as Peach Red Four Substance Decoction Granules Receive Market Approval

Stock News
·
Apr 20